Treatment of panic-like attacks with a long-acting analogue of somatostatin.

Abstract

Psychiatric evaluations were completed on four patients who were treated for "idiopathic flushing" with a long-acting analogue of somatostatin. All four patients had symptom profiles consistent with a diagnosis of panic disorder. All four experienced clinically significant relief from panic-like attacks while on the experimental medication. These findings suggest a possible role for somatostatin in the pathophysiology and treatment of panic disorder.

• Authors: J L Abelson, R M Nesse, A Vinik
• Journal: Journal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 10 Issue 2 Pg. 128-32 (Apr 1990) ISSN: 0271-0749 [Print] United States
• PMID: 2341587 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Octreotide

Topics

• Adult
• Anxiety Disorders (drug therapy)
• Fear
• Female
• Flushing (drug therapy)
• Humans
• Male
• Middle Aged
• Octreotide (therapeutic use)
• Panic
• Psychiatric Status Rating Scales
• Time Factors